8 results
8-K
EX-2.1
CLDX
Celldex Therapeutics Inc.
1 Nov 16
Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals
12:00am
8-K
EX-2.1
CLDX
Celldex Therapeutics Inc.
29 May 09
Celldex Therapeutics, Inc. Enhances Precision Targeted Immunotherapy Platform with the Acquisition of CuraGen Corporation
12:00am
425
EX-2.1
CRGN
Curagen Corp
29 May 09
Business combination disclosure
12:00am
425
EX-2.1
CLDX
Celldex Therapeutics Inc.
23 Oct 07
Business combination disclosure
12:00am
8-K
EX-2.1
CLDX
Celldex Therapeutics Inc.
23 Oct 07
Entry into a Material Definitive Agreement
12:00am
8-K
EX-2.1
i9mo0foniewg24wd5
12 Dec 00
Current report
12:00am
8-K
EX-2.2
jawbg824qax4 ousfmwc
12 Dec 00
Current report
12:00am
8-K
EX-2.1
yxvych24t
20 Mar 96
Acquisition or disposition of assets
12:00am
- Prev
- 1
- Next